English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Nov 29, 2025

FOLFIRINOX shows potential as second-line therapy for advanced biliary tract cancer

Patient Daily | Nov 29, 2025

England’s progress on blood pressure control reverses after pandemic disruption

Patient Daily | Nov 29, 2025

University of Seville study maps early brain structure changes in schizophrenia

Patient Daily | Nov 29, 2025

Penn Medicine's bioethics department honored with ASBH Cornerstone Award after three decades

Patient Daily | Nov 29, 2025

UK MedTech leaders respond positively but cautiously after Autumn 2025 budget

Patient Daily | Nov 29, 2025

Northwestern Medicine Kishwaukee marks 100th robotic-assisted bronchoscopy milestone

Patient Daily | Nov 29, 2025

Experts urge regular hearing checks for people living with diabetes

Patient Daily | Nov 29, 2025

Baylor psychiatrist discusses signs of shopping addiction during holiday season

Trending

+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift

Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks

+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'

+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'

  • « First
  • «
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily